MedicinePhysics

A. Dash, M. Pillai, F. Knapp

2015.2.17Nuclear Medicine and Molecular Imaging

DOI: 10.1007/s13139-014-0315-z

tlooto Summary

A broad understanding and discussion of the issues associated with 177Lu production and processing approaches would not only ensure sustained growth and future expansion for the availability and use of 177Lu-labeled radiopharmaceuticals, but also help future developments.

Abstract

Abstract is not available.

Citation format

DASH, A.; PILLAI, M.; KNAPP, F. Production of 177lu for targeted radionuclide therapy: Available options. Nuclear Medicine and Molecular Imaging, 2015, 49: 85–107.